A detailed history of Geode Capital Management, LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 630,369 shares of CELC stock, worth $7.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
630,369
Previous 493,851 27.64%
Holding current value
$7.89 Million
Previous $8.09 Million 16.18%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$13.98 - $19.15 $1.91 Million - $2.61 Million
136,518 Added 27.64%
630,369 $9.4 Million
Q2 2024

Aug 09, 2024

BUY
$14.1 - $20.78 $2.03 Million - $3 Million
144,129 Added 41.21%
493,851 $8.09 Million
Q1 2024

May 13, 2024

BUY
$13.74 - $21.6 $361,279 - $567,950
26,294 Added 8.13%
349,722 $7.55 Million
Q4 2023

Feb 13, 2024

BUY
$8.7 - $15.02 $136,276 - $235,273
15,664 Added 5.09%
323,428 $4.71 Million
Q3 2023

Nov 13, 2023

BUY
$8.96 - $10.75 $117,402 - $140,857
13,103 Added 4.45%
307,764 $2.81 Million
Q2 2023

Aug 11, 2023

BUY
$9.39 - $12.18 $1.52 Million - $1.97 Million
161,773 Added 121.74%
294,661 $3.24 Million
Q1 2023

May 15, 2023

BUY
$9.4 - $12.82 $574,828 - $783,968
61,152 Added 85.25%
132,888 $1.36 Million
Q4 2022

Feb 13, 2023

BUY
$7.55 - $14.01 $4,832 - $8,966
640 Added 0.9%
71,736 $1.01 Million
Q3 2022

Nov 14, 2022

SELL
$8.0 - $10.64 $112,120 - $149,119
-14,015 Reduced 16.47%
71,096 $713,000
Q2 2022

Aug 12, 2022

SELL
$5.35 - $10.11 $363,516 - $686,944
-67,947 Reduced 44.39%
85,111 $774,000
Q1 2022

May 13, 2022

BUY
$7.93 - $13.33 $4,932 - $8,291
622 Added 0.41%
153,058 $1.43 Million
Q4 2021

Feb 11, 2022

BUY
$11.96 - $19.35 $96,660 - $156,386
8,082 Added 5.6%
152,436 $2.01 Million
Q3 2021

Nov 12, 2021

BUY
$17.35 - $24.87 $299,148 - $428,808
17,242 Added 13.56%
144,354 $2.6 Million
Q2 2021

Aug 13, 2021

BUY
$14.25 - $30.93 $1.11 Million - $2.42 Million
78,113 Added 159.42%
127,112 $3.05 Million
Q1 2021

May 12, 2021

BUY
$10.43 - $17.8 $310,563 - $530,012
29,776 Added 154.9%
48,999 $702,000
Q4 2020

Feb 12, 2021

SELL
$5.13 - $11.72 $395 - $902
-77 Reduced 0.4%
19,223 $177,000
Q3 2020

Nov 13, 2020

SELL
$5.1 - $7.07 $2,646 - $3,669
-519 Reduced 2.62%
19,300 $111,000
Q2 2020

Aug 13, 2020

SELL
$4.42 - $11.04 $132,383 - $330,659
-29,951 Reduced 60.18%
19,819 $137,000
Q1 2020

May 14, 2020

BUY
$5.79 - $11.78 $17,462 - $35,528
3,016 Added 6.45%
49,770 $323,000
Q4 2019

Feb 13, 2020

BUY
$9.47 - $16.71 $606 - $1,069
64 Added 0.14%
46,754 $497,000
Q3 2019

Nov 12, 2019

BUY
$15.74 - $23.65 $13,725 - $20,622
872 Added 1.9%
46,690 $792,000
Q2 2019

Aug 14, 2019

BUY
$19.88 - $25.0 $148,742 - $187,050
7,482 Added 19.52%
45,818 $1.15 Million
Q1 2019

May 14, 2019

BUY
$18.38 - $24.44 $60,672 - $80,676
3,301 Added 9.42%
38,336 $839,000
Q4 2018

Feb 13, 2019

BUY
$20.87 - $29.05 $61,149 - $85,116
2,930 Added 9.13%
35,035 $840,000
Q3 2018

Nov 13, 2018

BUY
$20.96 - $30.77 $89,268 - $131,049
4,259 Added 15.29%
32,105 $923,000
Q2 2018

Aug 14, 2018

BUY
$16.13 - $26.99 $449,155 - $751,563
27,846 New
27,846 $691,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $187M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.